Triple‐Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells’ Function and Facilitate Cancer Metastasis
Advanced Science · 2026-08 · 13 (44)
DOI: 10.1002/advs.75655 ↗At a glance
Journal article in Advanced Science, published online on 2026-05-25. Written by Mingheng Yuan and 6 co-authors. Institution: Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macao SAR, China. Major MEDLINE topics: Triple Negative Breast Neoplasms, Killer Cells, Natural, Interleukin-8, Chemokine CXCL1. 66 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Education Frontiers Science Centre for Precision Oncology, University of Macau, The Science and Technology Development Fund (FDCT), Macau S.A. R, China.
Abstract (original language)
Triple‐negative breast cancer (TNBC) is the most aggressive breast cancer subtype with high metastatic potential and limited treatment options. Natural killer (NK) cells represent a promising immunotherapy strategy due to their innate tumor‐killing capacity, but their efficacy against TNBC remains limited. We found that TNBC cells, particularly the mesenchymal‐like subtype, exhibited greater resistance to NK cells compared to non‐TNBC cells. Mechanistic studies indicate that TNBC cells’ survival in response to NK cells occurs in three phases. First, within 1 h of NK cell co‐culture, TNBC cells accumulate reactive oxygen species (ROS), which upregulate C‐X‐C motif chemokine ligand 1 (CXCL1) and interleukin 8 (IL8) expression in an NF‐κB− and ERK/JNK−AP‐1‐dependent manner. Second, secreted CXCL1/IL8 binds to C‐X‐C motif chemokine receptor 1/2 (CXCR1/2), activating the AKT−BCL‐2 pathway to enhance cancer cell survival and suppress NK cell function by downregulating NKG2D, TRAIL, and IFN‐γ expression. Third, CXCL1/IL8−CXCR1/2 autocrine loop further amplifies their own synthesis and induces programmed cell death 1 ligand 1 (PD‐L1) expression via NF‐κB and ERK/JNK−AP‐1 pathways. High CXCL1/IL8 expression correlates with reduced NK cell infiltration and shorter distant‐metastasis‐free survival in breast cancer patients. Combinatorial application of CXCR1/2 inhibitor with anti‐PD‐L1 antibody can overcome NK cell dysfunction and reduce TNBC metastasis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macao SAR, China.
- Ministry of Education Frontiers Science Center For Precision Oncology, University of Macau, Taipa, Macao SAR, China.
ORCID profiles: Mingheng Yuan
Funding
- Ministry of Education Frontiers Science Centre for Precision Oncology, University of Macau
- The Science and Technology Development Fund (FDCT), Macau S.A. R, China
Cite
APA
Yuan, M., Yang, H., Wu, R., Hao, M., Chu, X., Deng, C., & Luo, K. Q. (2026). Triple‐Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells’ Function and Facilitate Cancer Metastasis. Advanced Science, 13(44). https://doi.org/10.1002/advs.75655
Vancouver
Yuan M, Yang H, Wu R, Hao M, Chu X, Deng C, et al. Triple‐Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells’ Function and Facilitate Cancer Metastasis. Advanced Science. 2026;13(44). doi:10.1002/advs.75655
BibTeX
@article{Yuan2026,
author = {Yuan, Mingheng and Yang, Hongmei and Wu, Renfei and Hao, Meng and Chu, Xiangpeng and Deng, Chuxia and Luo, Kathy Qian},
title = {Triple‐Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells’ Function and Facilitate Cancer Metastasis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {44},
doi = {10.1002/advs.75655}
}
EUVIMED